期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非ST段抬高型急性冠脉综合征患者的抗血小板治疗——2014年美国NSTE-ACS治疗指南的更新 被引量：11

下载PDF
导出
摘要 2014年9月,美国心脏协会（American Heart Association,AHA）/美国心脏病学会（American College of Cardiology,ACC）结合最新循证医学证据更新了非ST段抬高型急性冠脉综合征（non-ST-segment elevation of acute coronary syndrome,NSTE-ACS）管理指南。指南指出，抗血小板治疗仍是NSTE—ACS药物治疗的基石，对确诊或疑似NSTE—ACS患者，无论采用早期侵入性策略还是缺血指导策略，早期启用抗血小板治疗均可有效减少血栓事件，改善预后。
作者 师树田 聂绍平
机构地区 首都医科大学附属北京安贞医院急诊中心
出处 《中国医刊》 CAS 2015年第6期21-24,共4页 Chinese Journal of Medicine
基金 北京市自然科学基金(7141003) 国家自然科学基金(81270284)
关键词 急性冠脉综合征 NSTE-ACS ST段抬高 治疗应用 美国心脏协会 美国心脏病学会 ELEVATION 依替巴肽 阿昔单抗 非致死性
分类号 R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1Bhatt DL, Hulot JS, Moliterno D J, et al. Antiplatelet and anticoagula- tion therapy for acute coronary syndromes [ J ]. Circ Res, 2014,114 (12) :1929-1943.
  • 2Gurbel PA,Bliden KP, Buffer K, et al. Randomized double-blind as- sessment of the ONSET and OFFSET of the antiplatelet effects of ti- cagrelor versus clopidogrel in patients with stable coronary artery dis- ease :the ONSET/OFFSET study [ J ]. Circulation ,2009 ( 120 ) :2577 -2585.
  • 3Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clo- pidogrel in patients withacute coronary syndromes [ J ]. N Engl J Med,2007,357(20) :2001-2015.
  • 4Roe MT, Goodman SG, Ohman EM, et al. Elderly patients with a- cute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced- dose prasugrel versus standard-dose clopidogrel [ J ]. Circulation, 2013,128(8) :823-833.
  • 5Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortali- ty following acute coronary syndromes [ J ]. JAMA, 2007,298 ( 7 ) : 765 -775.
  • 6Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with pra- sugrel in non-ST-segment elevation acute coronary syndromes[ J]. N Engl J Med ,2013,369 ( 11 ) :999-1010.
  • 7Bellemain-Appaix A, O' Commor SA, Silvain J, et al. Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis [ J ]. JAMA, 2012, 308(23) :2507-2516.
  • 8Harem CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting with- out persistent ST-segment elevation: The Task Force for the manage- ment of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J, 2011,32 ( 23 ) :2999-3054.
  • 9Lip GY, Huber K, Andreotti F, et al. Antithrombotic managementof atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a con- sensus document of the European Society of Cardiology Working Group on Thrombosis[J]. Eur Heart J,2010,31 ( 11 ) :1311-1318.
  • 10Lamberts M, Gislason GH, Olesen JB, et al. Oral antieoagulation and antiplatelets in atrial fibrillation patients after myocardial infarc- tion and coronary intervention [ J ]. J Am Coil Cardiol, 2013,62 (11) :981-989.

同被引文献117

  • 1徐嘉欣,吴辉,褚庆民,周小雄.冠心病毒瘀病机探析[J].辽宁中医药大学学报,2019,0(11):170-173. 被引量：9
  • 2董帅,王辉,谢治深.丹参功用本草考证及现代药理认识[J].辽宁中医药大学学报,2019,0(11):152-155. 被引量：94
  • 3陈灏珠,林果为.实用内科学[M].第13版.北京:人民卫生出版社,2009:2005-2011.
  • 4中国中西医结合学会心血管学会.冠心病中医辨证标准[J].中西医结合杂志,1991,11(5):257.
  • 5柏太柱,全昌发,赵庆禧.急性非ST段抬高性心肌梗死患者冠状动脉病变特点及其临床意义[J].中国动脉硬化杂志,2007,15(10):780-782. 被引量：24
  • 6沈绍功,王承德,闫希军.中医心病诊断疗效标准与用药规范[M].北京:北京出版社,2005:26-29.
  • 7Gensini GG. A more meaningful scoring system for determi- ning the severity of coronary heart disease [ J ]. Am J Cardi- o1,1983,51 (3) :606.
  • 8Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC) [J]. Eur Heart J, 2016, 37(3):267-315.
  • 9Lip GY, Windecker S, Huber K, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions:a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association(EHRA), European Association of Pereutaneous Cardiovascular Interventions(EAPCI) and European Association of Acute Cardiac Care(ACCA) endorsed by the Heart Rhythm Society(HRS) and Asia-Pacific Heart Rhythm Society(APHRS)[J]. Eur Heart J, 2014, 35(45):3155-3179.
  • 10Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation:an upd- ate of the 2010 ESC Guidelines for the management of atrial fibrilla- tion. Developed with the specialcontribution of the European Heart Rhythm Assoeiation[J].Eur Heart J, 2012, 33(21):2719-2747.

引证文献11

二级引证文献65

中国医刊
2015年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部